ArticleHaematologica2023

Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma.

Mi Kwon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.